A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Experts explain what the most recent research says about GLP-1 drugs, including Ozempic, and their link to thinning hair.

But semaglutide isn't without side effects. Some users have reported gastrointestinal issues, and a new study suggests that ...

To curb hunger and help achieve weight loss, some natural alternatives to Ozempic (semaglutide) may help. See what the ...

Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study ...

Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this.

Berberine is a powder made from different plants. It has many benefits, including improving blood sugar levels, reducing ...

Ozempic is FDA approved for use in adults with ... Compounded semaglutide has not gone through the same review process as FDA-approved drugs, so it is unclear how safe or effective these products ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

Newsweek has contacted Ozempic manufacturer Novo Nordisk for ... Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis. JAMA Neurology.